You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 20, November 26, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Viral Infections
 •Critical Care/ Intensive Care Medicine
 •Adult Critical Care
 •Drug Therapy
 •Drug Therapy, Other
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reactivation of Cytomegalovirus Infection in Critically Ill Immunocompetent Patients

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The cohort study by Dr Limaye and colleagues1 evaluated reactivation of cytomegalovirus (CMV) infection in critically ill patients. The study used the current generation of extremely sensitive DNA amplification tests for the detection of CMV reactivation in patients who did not have traditional reasons to be immunosuppressed. Although the findings provided the rationale for further investigation, we believe there are aspects of this study that require further research to better understand the implications of the findings.

First, the authors combined many different patient populations into the category of "critical illness," ranging from acute myocardial infarction to burn injury to sepsis. This difference in patient populations is reflected, for example, in substantial variability between the burn intensive care unit (ICU) and cardiac care ICU in the incidence of CMV reactivation (55% vs 15%, respectively) and duration of CMV reactivation (median, 20 days vs 4 days) and between the . . . [Full Text of this Article]

Amanda Peppercorn, MD
apepp@med.unc.edu

Jonathan Serody, MD
Department of Medicine

Bruce Cairns, MD
Department of Surgery
University of North Carolina
Chapel Hill



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Cytomegalovirus Reactivation in Critically Ill Immunocompetent Patients
Ajit P. Limaye, Katharine A. Kirby, Gordon D. Rubenfeld, Wendy M. Leisenring, Eileen M. Bulger, Margaret J. Neff, Nicole S. Gibran, Meei-Li Huang, Tracy K. Santo Hayes, Lawrence Corey, and Michael Boeckh
JAMA. 2008;300(4):413-422.
ABSTRACT | FULL TEXT  

RELATED LETTER

Reactivation of Cytomegalovirus Infection in Critically Ill Immunocompetent Patients—Reply
Ajit P. Limaye, Wendy M. Leisenring, and Michael Boeckh
JAMA. 2008;300(20):2368.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.